About HumanFirst
HumanFirst is a company based in San Francisco (United States) founded in 2017 by Andy Coravos was acquired by Icon in February 2024. It operates as a SaaS (Software-as-a-Service). HumanFirst has raised $14.9 million across 2 funding rounds from investors including ICON, Maverick Ventures and Arkitekt Ventures. The company has 344 employees as of December 31, 2021. HumanFirst offers products and services including Atlas Platform, Atlas API, and HumanFirst Institute Courses. HumanFirst operates in a competitive market with competitors including Endotronix, Edwards Lifesciences, CoachCare, BioIntelliSense and Oxehealth, among others.
- Headquarter San Francisco, United States
- Employees 344 as on 31 Dec, 2021
- Founders Andy Coravos
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Icon Plc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of HumanFirst
HumanFirst offers a comprehensive portfolio of products and services, including Atlas Platform, Atlas API, and HumanFirst Institute Courses.
Comprehensive platform for DHTs and digital biomarkers offered.
API for building research tools on Atlas platform.
Courses to enable measures for research purposes provided.
People of HumanFirst
Unlock access to complete
Unlock access to complete
Funding Insights of HumanFirst
HumanFirst has successfully raised a total of $14.9M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $12 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $12.0M
-
First Round
First Round
(12 Nov 2019)
- Investors Count 18
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2021 | Amount | Series A - HumanFirst | Valuation | Maverick Ventures | |
| Nov, 2019 | Amount | Seed - HumanFirst | Valuation | Maverick Ventures , Founder Collective |
|
Investors in HumanFirst
HumanFirst has secured backing from 19 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include ICON, Maverick Ventures and Arkitekt Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage tech and life-sciences firms are funded across the US.
|
Founded Year | Domain | Location | |
|
Investments are made in health technology by Arkitekt Ventures.
|
Founded Year | Domain | Location | |
|
Seed and early-stage technology companies are funded by Lux Capital.
|
Founded Year | Domain | Location |
Investments & Acquisitions by HumanFirst
Financial Statements - HumanFirst
Humanfirst Comparisons
Competitors of HumanFirst
HumanFirst operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endotronix, Edwards Lifesciences, CoachCare, BioIntelliSense and Oxehealth, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| domain | founded_year | HQ Location |
Medical devices for structural heart disease are developed and provided.
|
|
| domain | founded_year | HQ Location |
Remote monitoring platform for tracking patient activity
|
|
| domain | founded_year | HQ Location |
Vital signs are monitored via a single-use patch and platform.
|
|
| domain | founded_year | HQ Location |
Contactless patient monitoring is provided for mental health facilities.
|
|
| domain | founded_year | HQ Location |
Provider of imaging technologies for medical diagnosis and treatments
|
Frequently Asked Questions about HumanFirst
HumanFirst was founded in 2017 and raised its 1st funding round 2 years after it was founded.
HumanFirst is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Andy Coravos is the current CEO of HumanFirst. They have also founded this company.
HumanFirst is a funded company, having raised a total of $14.9M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2.9M, raised on Nov 12, 2019.
As of Dec 31, 2021, the latest employee count at HumanFirst is 344.
HumanFirst, now part of ICON, a leading clinical research organization, is dedicated to advancing digital health technologies. Solutions are provided for pharmaceutical and biotech companies through platforms like Atlas, which supports digital health technologies (DHTs) and digital biomarkers. Additional offerings include APIs for research tool development and educational courses through the HumanFirst Institute. Collaboration with ICON-sponsored Mapi Research Trust is aimed at enhancing Atlas capabilities. The focus remains on enabling evidence-based decisions and aligning industry measures through ontology and research contributions.
HumanFirst's top competitors include Endotronix, TestCard and Oxehealth.
HumanFirst offers Atlas Platform, Atlas API, and HumanFirst Institute Courses.
HumanFirst has 19 investors. Key investors include ICON, Maverick Ventures, Arkitekt Ventures, Lux Capital, and Boost VC.